Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trialKelly L. Bolton, Eytan M. Stein, Abhay Singh et al.|Blood|2025Cited by 2
IDH1/2-mutant clonal hematopoiesis: A novel driver of autoinflammatory diseaseGriffen Mustion, Kelly L. Bolton, Flore Castellan et al.|Blood|2025Cited by 0